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ABSTRACT 
David Opare Kennedy  
 
LIMS IMPLEMENTATION IN A GENOTYPING STUDY 
 
Discovery laboratories are dealing with DNA sequencer-based technologies which have 
seen great advancement over the past decade, resulting in several steps of the genotyping 
process becoming automated. This, in turn, has led to increased throughput. Laboratory 
Information Management Systems (LIMS) are needed to organize data flow as large 
amounts of data are difficult to process by hand.  A commercially developed LIMS was 
implemented at a Clinical Pharmacology Division laboratory of Indiana University, 
Indianapolis, during a P450 2D6 genotyping study. The LIMS application used was 
Biotracker
TM
 (Ocimum Biosolutions), and its modular design led users through each step 
of the genotyping process, from starting an experiment to the storing of output data from 
the genotype detection step. This ensured that every DNA sample was handled in an 
identical manner and all the necessary data were captured. The application helped design 
protocols and experiments, and manage different projects utilizing laboratory resources 
from the same inventory source, as in any typical laboratory. DNA samples, reagents, 
instruments, and generated data were also easily recorded and tracked. LIMS provide 
functions to trace back to protocols, inventories, projects, files or sample source for any 
genotype data.  One of the features of LIMS that is not crucial to academic laboratories 
but was found useful during this project was the audit trail functionality, which allowed 
researchers to know who carried out what experiment at what time, and also to track 
viii 
 
inventories. Workflows of projects were also designed, and submitted for review and 
approval.  Another aspect of this project was a survey to find out the knowledge and 
attitudes toward LIMS in academic research. It was observed that most academic 
researchers are not familiar with the total capabilities of LIMS, defined as special 
computer software that is used in the laboratory for the management of samples, 
inventories, laboratory users, instruments, standards and other laboratory functions such 
as invoicing, plate management, and work flow automation.  However, several software 
technologies are employed but mostly for data storage and instrument integration, which 
normally come with vendor-specific instruments.  Also, most respondents in laboratories 
conducting genotyping studies and DNA sequencing are more likely to use some form of 
LIMS. Lack of knowledge was cited as the most prevalent reason for not having used 
LIMS. 
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CHAPTER ONE: INTRODUCTION  
1.1. Laboratory Information Management Systems (LIMS) 
LIMS were originally developed in-house by organizations to streamline their 
data throughput and reporting processes. This took considerable time and resources to 
implement. Custom-built systems were later designed by independent systems 
development companies to run in specific laboratories, and offered increased flexibility 
and functionality (Gibbon, 1996). The main function of LIMS is to help to manage 
laboratory processes workflow precisely. Their use also encourages good laboratory 
practices by standardizing protocols, recording, and annotating data from every step of 
the workflow.   
A number of LIMS have been developed to meet different needs of commercial as 
well as academic research laboratories. Among these are Labware (Labware Inc), 
LabVantage sapphire (Labvantage), Starlims (Starlims Corporation), Corelims (Core 
Informatics), Biotracker (Ocimum Biosolutions), Sample Manager (Thermo Scientific), 
and Labworks (Perkin-Elmer).  Among LIMS developed to meet the challenges of 
laboratory workflow in academic research is TaqMan Information Management System 
(TIMS), a suite of tools written in Visual Basic developed specifically for genotyping 
laboratories using the Taqman technology for SNP genotyping (Monnier, 2005). It is 
aimed at improving data workflow, preventing errors linked to managing data by hand, as 
well as saving time. CLIMS (Crystallography LIMS) was specifically designed to 
manage protein crystallization workflow and data (Isler, 2004). It features a graphical 
user interface to a relational database, and assists in all aspects of protein-crystallization 
projects (protein expression, handling, crystallization optimization, visualization of 
 2 
 
results and preliminary diffraction data).  Prilusky et al. (2005) designed HaIX, an open 
source LIMS for managing all types of experiments on the way from cloning through to 
structure determination in a structured manner allowing extensive data mining, and 
creation of any protocol.  It is built around a three-tier architecture model. A web browser 
on the client’s computer, the application and business logic which is PHP based 
supported by an Apache web-server, and a PostgreSQL to manage the storage and DB-
server third tier. This was built for both small and large scale laboratories. A Microarray 
Analysis and Retrieval System (MARS) provides a comprehensive Minimum 
Information About a Microarray Experiment (MIAME) supportive suite for storing, 
retrieving, and analyzing multicolor microarray data, and comprises LIMS, a quality 
control management, as well as a user management system (Maurer, 2005). A minimal 
LIMS, called PACLIMS (Phenotype Assay Component LIMS) was developed to record 
data and track mutants. This system was designed to accommodate the experimental 
protocol as it evolved and fulfill the role of process control by enforcing the steps of the 
protocol (Donofrio, 2005). This software reduces laboratory and data entry errors while 
allowing the data generated at different locations to be entered.  
 
1.2. Single Nucleotide Polymorphisms (SNPs) and genotyping  
SNPs are genetic markers used as tools in biological, genetic, medical, and 
pharmacological applications due to their abundance and slow mutation rate within 
generations. SNPs occur when a single nucleotide (Adenine-A, Thymine-T, G-Guanine, 
C-Cytosine) in the DNA sequence in a region of the genome is changed, compared with 
what is observed in majority of the population.  About 99.9% of the DNA sequence of 
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one individual is identical to that of another, and 80% of the remaining 0.1% will be 
SNPs. Both versions of the single base substitution of one nucleotide with another in the 
DNA sequence occur in the general population at a frequency greater than 1% (Venter, 
2001; Collins et al, 1998; Gingeras, 2007). In an entire human genome there are 
approximately 10 to 30 million potential SNPs, many of which have unknown 
associations. SNPs represent the most frequent form of DNA variation and disease-
causing mutations in many genes, and their discovery and mapping involve several 
strategies that are either experimental or in-silico. Experimental SNP discovery is the 
most widely used but involves complex processes and is expensive. In-silico discovery 
makes use and takes advantage of large data sets with potential SNP information that 
have been generated for other purposes but not yet used as a SNP information source 
(Useche, 2001). SNPs can change the function or the regulation of a protein, and are also 
useful as genetic markers that can be used to find the actual DNA sequence variants that 
cause differences in gene function or regulation which directly contribute to disease 
processes (Roeder, 2005). Another significant goal of SNP discovery is to identify those 
that are associated with significant biological effects in response to chemical drugs 
(Shubbert, 2001; Stamer, 2005; Stamer and Stuber, 2007). A large percentage of people 
given a drug respond in the intended medically beneficial way, however, some smaller 
percentage might either have no response or have a life threatening response and death. 
 
SNPs form the basis of genotyping, which is a technique for measuring genetic 
variations between individuals due to changes in base pairing in the DNA sequence.  
There are several different SNP genotyping experimental methods and these consist of 
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various combinations of different allele-discrimination and signal detection methods. 
Many of these methods have been developed into commercial products with a 96- or 384-
well format and automation, such as single-base extension-based SNPStream (Orchid 
Bioscience), and Pyrosequencing's high throughput system obtaining a throughput of 
10000 genotypes a day, Invader (combined with PCR), fluorescent polarization-based 
methods, and dynamic allele-specific hybridization (DASH). These technologies are 
capable of tens of thousands of genotypes per day with automation, making large-scale 
association studies possible (Kwok, 2001; Howard, 1999; Abravaya, 2003; Klito, 2007; 
Olivier, 2005; Syvanen, 2001; McGuigan, 2002). With the advances in DNA sequencer-
based technologies, it has become possible to automate several steps of the genotyping 
process leading to increased throughput, generating about 10,000 genotypes per day. 
Recent years have seen many reports in the literature announcing the results of studies 
linking a gene variant to an increased risk for common diseases such as diabetes (Saxena, 
2007), myocardial infarction (Helgadotir, 2007), breast cancer (Easton, 2007; Hunter, 
2007; Shen, 2006; Santella, 2005; Kennedy, 2005), as well as factors associated with 
drug metabolism (Borges, 2007; Lim, 2006; Shubbert, 2001; Stamer and Stuber, 2007; 
Kircheiner, 2004; Giacomini 2007). 
 
1.3. Cytochromes P450  
Cytochromes P450 are a superfamily of heme enzymes present in living things 
(Nelson, 1996). Currently, the number of P450s with known sequences, either as 
nucleotide sequences or amino acid sequences are about 8000 (Nelson, 2008). P450s and 
their respective genes are named with the abbreviation CYP followed by an Arabic 
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numeral which expresses the family number, e.g. CYP2. This number may be associated 
with the function of the enzyme, or it may have been chosen rather arbitrarily. A family is 
divided further to create a subfamily based on higher degree of sequence similarity, and 
these subfamilies within one family are labeled sequentially as, e.g., CYP2D. Individual 
members of a family or subfamily are labeled again by Arabic numerals (e.g., CYP2D6). 
More than 7700 distinct CYP sequences are known. Human CYPs are primarily 
membrane-associated proteins, located either in the inner membrane of mitochondria or 
in the endoplasmic reticulum of cells. They are responsible for metabolising thousands of 
endogenous and exogenous compounds. Most CYPs can metabolize multiple substrates, 
and many can catalyze multiple reactions. In the liver, these substrates include drugs and 
toxic compounds as well as metabolic products such as bilirubin (a breakdown product of 
hemoglobin). In drug metabolism, cytochrome P450 is probably the most important 
element of oxidative metabolism (a part of phase I metabolism) in humans (metabolism 
in this context being the chemical modification or degradation of chemicals including 
drugs and endogenous compounds). P450 are also present in many other tissues of the 
body including the mucosa of the gastrointestinal tract, and play important roles in 
hormone synthesis and breakdown, such as in estrogen and testosterone synthesis and 
metabolism, cholesterol synthesis, and vitamin D metabolism.   
 
The impact of decreased activity of CYP2D6 on drug treatment may be extremely 
important. Variability of its activities in human liver samples may be ascribed to genetic 
polymorphism as CYP2D6 is not inducible. It causes the presence of three main 
phenotypes of oxidative metabolism of drug substrates of this enzyme. These three 
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phenotypes are classified as the slow metabolizers (with defective CYP2D6 alleles), the 
extensive (or rapid) metabolizers (with the wild-type allele or with alleles having 
nucleotide changes not causing altered activity of CYP2D6), and the ultrarapid ones with 
multiple genes for the functional CYP2D6 enzyme.  
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CHAPTER TWO: BACKGROUND 
2.1. Genotyping and LIMS 
A typical genotyping process involves several steps, which can generally be 
divided into two, sample preparation and allele detection. Sample preparation involves 
purification of DNA from blood, which is often labor-intensive, time-consuming, and 
costly and enhances the risk of cross-contamination of samples. Sample preparation steps 
involve sample collection, sample tracking, DNA extraction and purification, DNA 
tracking, PCR plate tracking, and use of instruments. A robust system for the 
management of sample identity and history is therefore required for any high throughput 
laboratory to document sample ID, date received, and any related information. Every 
PCR plate must have a reference to a template that details the plate contents and a unique 
identifier that allows the tracking of specific genotypes back to the plate.   
Great advances have been made in allele detection tests because novel 
technologies for DNA analysis have been developed, and this has led to more data being 
generated per genotyping. Owing to the multi-step nature of genotyping much planning is 
needed to streamline an effective workflow. The larger the laboratory or the bigger the 
genotyping project, the higher the complexity of managing all these resources.  A number 
of data management issues are encountered in high-throughput genotyping for a large 
disease mapping project. The data management system used must allow the import of raw 
data from the laboratory as well as the processing of that raw data to generate finished 
genotypes. Error analysis and correction of the finished data, which requires the ability to 
trace back to the raw data, the compilation of all data, and export in a finished form to 
suitable programs for genetic analysis are all important steps.  There is therefore a strong 
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need for a software system that can help with the tracking of samples, capture, and 
management of data at different steps of the process.  
 
2.2. Current practice in academia 
Discovery laboratories like academic laboratories carry out sequencing, 
genotyping, gene expression, proteomics, metabolomics, cell biology and general life 
science projects. Traditionally, upon approval of project proposal, the responsible 
personnel assemble their reagents, labware, and make reservations for instruments. Much 
time is lost looking for reagents and vendors information, and placing orders for out of 
stock reagents. Instruments are usually reserved in a notebook or on a sign-up sheet 
attached to the instrument. Samples are collected, and the experiments are carried out 
with the aid of protocols from assay kits supplied by a manufacturer or they are 
downloaded or assembled from a website, or built from scratch with information from 
literature. This may be typed out and printed for storage and dissemination. Mostly, data 
is transferred from instruments to an external storage site, usually a computer used only 
for data processing, resulting in redundancy in datasets scattered in different directories. 
Sometimes, results are printed from instruments to storage in physical files. Other issues 
are data integrity and accountability, as data management is mostly done by hand, and 
getting data off instruments into a storage system may not be in a manner that is lossless.  
Data management by hand presents a situation where it is difficult to link files to 
experiments and to the original sample. Results are published after data analysis, and the 
raw data is archived in a random or assigned directory on a computer, diskette or CD, or 
printed for filling and storage. This may be the end of the data and perhaps the study. 
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Most often these data cannot be located after several years of storage. During the next 
project, the whole cycle is repeated, sometimes even subsequent studies which may be 
similar to a previous one have to go through the whole cycle from the beginning, and 
investigators have to assemble all the logistics all over again. Much time and resources 
are spent in this repeating cycle. A typical challenge is inventory keeping. At best, 
reagents are stored in alphabetical order in cabinets or on shelves, but it is always 
difficult to locate or even identify items in refrigerators or freezers. Instrument sharing is 
also a problem. The major problem is that steps involved in project execution are not 
linked to a specific workflow but are all segregated.      
LIMS have over the past three decades flourished in the commercial sector 
(Vanderslice, 1990; Cagnd, 2004). Commercial sectors generated large datasets and 
needed automated processes to assimilate these, whereas in academia the data load 
generated could be easily managed by modest, conventional means with a spreadsheet 
application on a less sophisticated and expensive computer. LIMS serve to help manage 
workflow precisely and also encourage good laboratory practices by standardizing 
protocols, and recording and annotating data from every step of the workflow. It is also 
known that government regulatory requirements (Title 21, Code of Federal Regulations: 
Electronic Records and Electronic Signatures), have necessitated the use of LIMS in the 
commercial sector (Food and Drug Administration, 2003), but are non-existent in 
academia.  Atrium Research, a market research organization dedicated to scientific 
informatics in the United States, is one of the few informatics research companies that 
look at trends and implementations of LIMS, electronic laboratory notebooks (ELNs), 
and scientific data management systems. However, studies so far have centered on and 
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targeted the commercial sector. Shankar (2004) demonstrated through an ethnography 
study the record-keeping attitudes of academic researchers and called for more analysis 
of recordkeeping as an information infrastructure, and inquiry into the nature of the 
record in other kinds of knowledge production environments.  Some scientists believe 
that LIMS were initially created, developed, and applied exclusively in the commercial 
sector. Cost, failed implementation, and general resistance to computerized systems are 
among the factors that influenced the initial enthusiasm for LIMS usage (Perry, 2002). 
However, with the decline in the cost of LIMS, smaller commercial companies are able to 
implement them, and LIMS are appreciated as a valuable and even necessary tool in the 
commercial laboratory. However, LIMS have very little presence in academia (Viksna, 
2007; Steinlechner, 2001; Schreier, 2006; Hendricks, 2003).  A few laboratories have 
created open source software that may run a couple of processes such as high-throughput 
technologies. The National Cancer Institute started encouraging the use of Labvantage 
LIMS (Labvantage, 2002) for its cancer research programs. According to Perry (2002), 
there are two reasons for the difference between the commercial and academic use of 
LIMS, namely, the history of LIMS development and the special characteristics of 
academic research and development laboratories. He explained that in the early days, 
LIMS were custom-designed, labor-intensive applications. They were expensive, took 
years to implement, and were often unsatisfactory to end-users. However, large 
organizations wanted automation of routine operations to increase productivity and have 
used LIMS. The situation in academia was much different. Thus, LIMS implementation 
was traditionally limited to commercial laboratories that had both the need and the 
resources to accomplish this.  
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Furthermore, recent lawsuits regarding proprietary rights to discoveries have also 
sparked the need for LIMS and ELNs. LIMS have been thought to remain out of the 
financial reach of academic laboratories, and vendors do not consider them a potential 
profit-making business. Recently, several LIMS vendors have initiated academic 
pricing models.  
 
2.3. Proposed project 
One of the challenges of high-throughput SNP genotyping is to create an 
informatics environment that can support such a large data flow efficiently, such as for 
tracking blood and tissue samples to managing data at different steps of the research 
process. Owing to this multi-step nature of genotyping much planning is needed to 
streamline methods, instruments, reagents, and samples to facilitate an effective 
workflow. Currently, most academic laboratories handle inventorying by hand, using 
common software such as Microsoft Word and Excel. An efficient
 
tool is also needed to 
manipulate the large data output for further
 
analyses and final reporting.
 
This project 
aimed at using a commercially available Biotracker LIMS to manage the entire workflow 
of a study involving drug metabolism-related P450 genotypes in an academic research 
laboratory setting, from sample preparation to final report generation.  Biotracker 
architecture has a database management layer written in pure Java that makes it 
independent of databases, and supports Oracle, MySQL, SQL Server, and Sybase. It can 
run on any platform such as Windows, Linux, or Solaris. It has several modules which 
are interdependent and make for a smooth workflow (Figure 1). Biotracker was used at 
each step of the genotyping process from the start of the study to the storing of output 
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data to final reporting. This project involved the management of such an academic study 
usually conducted by scientists at the Clinical Pharmacology Division at Indiana 
University in Indianapolis, Indiana, without the use of LIMS. This is possibly the most 
popular cytochrome P450 among physicians and other health professionals, because of its 
genetic polymorphism.  
 
 
Figure 1: Interdependency of various modules in Biotracker 
 (Obtained from Biotracker manual) 
 
The use of LIMS in academia is not widespread despite the large number of 
commercial-off-the-shelf (COTS) systems as well as open source LIMS that are currently 
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available to universities. As part of this project, a short survey was conducted to assess 
the factors that may be influencing attitudes towards LIMS implementation in the 
academic community. This included obtaining responses from experienced scientists, 
technicians, and postdoctoral fellows.  Personal characteristics of respondents examined 
included age, sex, laboratory information, education, work experience, expertise of the 
laboratory, working hours, type of institution, instruments available, city or state of 
research. These were examined to shed light on the nature of the respondents and their 
work, and to see if any of these factors affected their LIMS usage. Knowledge 
characteristics looked at knowledge of LIMS. Questions were designed to determine 
whether respondents had any knowledge of LIMS or had used similar software. 
Respondents were also asked their reasons for not having used LIMS before. 
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CHAPTER THREE: METHODOLOGY 
3.1. Materials and methods 
Biotracker LIMS was obtained from Ocimum Biosolutions, Inc. (Indianapolis, 
Indiana). It is a multi-platform, multi-user, cost-effective software designed to improve 
laboratory performance. Biotracker is designed for sequencing, gene expression, 
genotyping assays, proteomics core labs, and bio-specimen banking facilities. The 
genotyping assays functionality was used in this project to manage, and track biological 
samples (blood), reagents, instruments, processes, and results at every stage of the 
project. Key features of Biotracker, such as integration support for Luminex, 
Autogenomics, SNP stream, or Illumina instruments, were not available on this student 
version.  The genotyping study was part of an on-going study at the Division of Clinical 
Pharmacology, Indiana University Medical School. The genotyping method was based on 
the Taq-It Mutation Detection Kit assay for P450-2D6 (Tm Bioscience Corporation, 
Toronto, Canada).   
 
3.2. Genotyping method overview 
The genotyping work was done in the laboratory of Professor Todd Skaar at the 
Clinical Pharmacology Division of Indiana University, Indianapolis. The Tag-It
TM
 
Mutation Detection Kit for P450-2D6 is designed to simultaneously detect a panel of 12 
small nucleotide variants found within the highly genetically polymorphic cytochrome 
P450-2D6 gene located on chromosome 22. The enzyme product of the P450-2D6 gene is 
involved in the oxidative metabolism of more than 100 clinically relevant drugs 
(Abraham, 2001). Enzyme activity varies with the genotype resulting in different drug 
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metabolism phenotypes (McElroy, 2000). The 12 small nucleotide changes tested for in 
this kit represent the most prevalent phenotypically-relevant variants within the P450-
2D6 gene. Eight blood samples received from Riley Hospital, Indianapolis, were used in 
this project.  
Briefly, a QIAamp DNA blood Mini Kit (Qiagen, Valencia, CA) was used to 
extract genomic DNA from the leukocyte portion of whole blood.  For each genomic 
sample being tested, two separate PCR reactions were performed (Figure 2). Each PCR 
reaction required 25 ng genomic DNA (total - 50 ng genomic DNA per sample). The first 
PCR (PCR-A) produced an alpha fragment (3.8 kb) used to detect the variants, as well as 
a duplication amplimer (3.2 kb) which indicates the presence of the duplication genotype. 
The second PCR (PCR-B) produces a beta fragment (2.6 kb) used to detect the variants, 
as well as a deletion amplimer (3.5 kb) indicative of the deletion genotype. After PCR 
amplification, the two reactions (PCR-A and PCR-B) were pooled. The pooled PCR 
product was then treated with Shrimp Alkaline Phosphatase (SAP) to inactivate any 
remaining nucleotides (particularly dCTP), and with Exonuclease I (EXO) to degrade any 
primers left over from the PCR reaction.  Allele Specific Primer Extension (ASPE) 
reaction was then carried out using 26 universally-tagged primers supplied in the ASPE 
primer mix. A 5 uL aliquot of the ASPE reaction was hybridized with the universal array 
(Bead Mix) in the presence of the hybridization buffer and incubated with Streptavidin, 
R-Phycoerythrin conjugate (reporter solution).  Samples were read on the Luminex® 100 
xMAP™ instrument and signal was generated for each of the 12 small nucleotide variants 
as well as for the duplication and deletion amplimers, if present. These fluorescence 
values were then analyzed to determine whether the wild-type/mutant allele for each of 
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the 12 small nucleotide variants had been detected or whether the samples carried an 
allele(s) with the deletion or duplication.  All the steps of the genotyping project and 
assay were monitored, and the DNA samples, reagents, instruments and workflow were 
tracked with Biotracker LIMS. 
 
Figure 2: P4502D6 assay overview 
 
 
3.3. LIMS functionality  
3.3.1. Starting Biotracker  
The investigator’s role was a LIMS administrator and a research scientist in the 
laboratory on this genotyping project. Initially, the administrator logged in through the 
window in Figure 3 with a software developer provided ID and password, created a 
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database server, set the LIMS configuration, and created users and assigned passwords 
and privileges.  
 
 
Figure 3: Biotracker LIMS log-in 
 
On entering the software, the LIMS window shows a menu bar (12 items), tool bar (10 
iconic items), navigator bar, work area, status bar, and scan barcode window (Figure 4).  
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Figure 4: Biotracker window 
 
Through the File menu item, the Administrator set the database connections, since client 
and server were installed on different machines, as in the window in Figure 5.  
 
Figure 5: Establishing database settings 
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3.3.2. System configuration 
System configuration was accessed through the File menu as in Figure 6.  
Configuration involved setting root password, password conditions, precision, and 
currency, date format, scientific notation for a given range, integration with Google 
Scholar, entering settings for outgoing (SMTP) mail server and Biotracker email, 
necessitating authentication from mail server, and selecting mail server requirements.  
 
 
Figure 6: System configuration 
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Accounts for other users in the laboratory were set up through the Administration module 
on the menu bar (Figure 7).  
 
 
Figure 7: LIMS administration management 
 
3.3.3. Users, laboratories, collaborators, vendor management 
Users were created for the Clinical Pharmacology laboratory namely, 
Professor/Head, Lab Manager, Technicians, and students.  An important aspect of 
Biotracker is that passwords are coupled with assigned laboratories, and together both are 
needed to login. This allowed the same user to access items in different laboratories. For 
the genotyping project, three laboratories were set up: Clinical Pharmacology, Laboratory 
Informatics, and Molecular Biology. Every researcher was assigned to a laboratory. 
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Authority level has well defined privileges, and each user was assigned levels according 
to their roles. Vendor and collaboration information included names, addresses, and 
contacts. 
 
3.3.4. Audit trail and electronic signature  
A record of electronic signatures was step up to show the sequence log of 
activity, various actions taken, the researcher names, time and date, and approval or 
rejection of data. Actions once performed on the system are logged into a non-editable 
audit trail. Thus, this module ensures full integrity of data and accountability of user 
actions (Figure 8). 
 
 
Figure 8: Audit trail configuration 
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3.3.5. Samples, plates, and inventory management 
Types of samples, plates, chemicals, primers, antibodies, and labware according 
to the manufacturer's instructions for the Tag-It Mutation detection kit for P450 2D6 were 
set up. This included names, catalogue numbers, prices, volumes or weight of reagents, 
consumables, and equipments.  Access to these items was through the menu bar or the 
tool bar icons. Inventory Management was used to keep track of chemicals, instruments, 
glassware, stock solutions and materials in all laboratories (Figure 9). The key features of 
this utility allowed researchers to catalog various inventory items, provide pertinent 
information about vendor location, and purchase orders. At this time, automatically 
updating stocks when they are used in an experiment was also set up. Barcode 
management allowed barcodes to be set up and used for inventorying (Figure 10). Plate 
tracking functionality was used to create 96 or 384 well plates. The 96-well plates were 
later associated to experiments and runs. 
 
Figure 9: Inventory management 
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Figure 10: Barcode design management 
 
3.3.6. Units management 
Different units of scientific measurements such as weight, volume, and 
concentration, were created for subsequent use through the Utilities menu. 
 
3.3.7. Experiment and protocol management 
From the Library menu, Experiment template was selected and used to create 
all the experiments according to the manufacturer's instruction for the Tag-It mutation 
detection assay.  The same was done for protocols, which were sent for approval after 
being designed (Figure 11) before use. Protocols created were for DNA extraction, 
Sample preparation, Multiplex PCR, Amplicon treatment, Multiplex ASPE, Bead 
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hybridization, Data acquisition, and Data analysis.  These were later used in the 
genotyping process and were archived for later use. Experiments and workflows were 
defined in templates, which were stored in a library. These were used to set up 
projects, and could be used for multiple projects. Workflow tab provided a 
diagrammatic workflow of the project, and protocols and experiments were added to 
workflows.  
 
Figure 11: Protocol design 
3.3.8. Project management 
Project Management module in Biotracker allows a researcher to establish a 
hierarchical model for project creation.  A project in the Biotracker architecture is a 
combination of experiments in a researcher-defined sequence. Experiments were 
created earlier with a Tag-It prefix, and stored in a library. Nine experiments were 
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created from the Tag-It mutation assay steps and used to create the LIMS-genotyping 
project, namely LIMS_TagIt P450 2D6_SP project.  The person in charge of this 
project was the Lab Manager. A hierarchical system of workflow was created from a 
library set up with protocols and experiments. This system leads to easy resource 
appraisals and result validations. Also, researchers get a composite picture of required 
resources, expected outputs and an approximation of costs involved, which can aid the 
decision-making process. Once a project was created, samples, personnel, 
instruments, and other resources were linked to it using the workflow feature. Project-
related roles for personnel were managed using Role Management. Each role had well 
defined privileges. The runs, experiments and the project itself were all set up to be 
reviewed and approved before execution. 
 
3.3.9. Report management 
The Report menu item (Figure 12) was accessed to allow the generation of 
customized reports of personnel, inventories, experiments, protocols, and projects. 
Several reports were created to show the overall outcome of the LIMS-genotyping 
project. The report for LIMS-TagIt P450 2D6 project was generated. Reports can be 
stored as PDF or printed for dissemination immediately after project completion or at 
a later time. 
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Figure 12: Report management 
 
3.4. LIMS in academia 
 
3.4.1. Research design 
Participants in the US were chosen from a list obtained from three scientific 
journals, namely, Carcinogenesis (Oxford Journals, UK), Science (American Association 
for the Advancement of Science, Washington, DC, USA), and FASEB journal 
(Federation of American Societies for Experimental Biology, Maryland, USA). These 
journals have contributors from a wide variety of research disciplines. A number of 
participants were selected from Indiana University-Purdue University Indianapolis. The 
selected participants were contacted by emails and phone. The protocol for this survey 
was approved by the Institutional Review Board of the Indiana University. 
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3.4.2. Data collection instruments 
The factors that affect the use of LIMS in academia were identified mainly from 
questionnaires administered to scientists across different disciplines in academic research 
in the implementation of LIMS in laboratory automation projects. These factors were 
analyzed in categories relevant to LIMS such as data storage, retrieval, and audit trail, 
and by subject of research such as sequencing, gene expression, genotyping assays, 
proteomics, and genomics. The study tool was a questionnaire with two parts, namely, 
(A) to collect demographic data about researchers, and (B) to ascertain the presence or 
absence of LIMS in the laboratories after a definition of LIMS had been provided.  
Factors that affect the usage of LIMS were also investigated. Knowledge of and use of 
LIMS were also be established.  
 
3.4.3. Demographics 
Participants included postdoctoral fellows, technicians and experienced scientists, 
regardless of age or sex, or region of residence.  Scientists from different research 
disciplines were recruited to eliminate any differences caused by research discipline and 
use of LIMS.  
 
3.4.4. Analysis of results 
Data analysis involved classifying respondents, responses and the items which 
characterize those responses. After ordering the responses frequencies were generated.  
Effect sizes and factor analysis were used in developing an index, and regression and 
Cronbach’s alpha (reliability) were used in analyzing the results. ANOVA test was 
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conducted to test for relationship between variables. Relationships analyzed included use 
of software technology and actual LIMS use, as well as laboratory experience and subject 
of research, on LIMS implementation. Respondents were grouped into specific areas of 
subject of research such as pharmacology, proteomics, genomics, genotyping, and these 
were correlated with their responses to questions relevant to LIMS use. Attitudes and 
usage of LIMS, or lack thereof, were analyzed from responses to specific questions 
administered. 
 
3.5. Project evaluation scheme 
The following concerns were addressed to evaluate the project. 
1) Was the project smoothly implemented? 
2) Did the project meet the overall goal(s)? 
3) Did the laboratory personnel see the benefits of the project? 
4) Was the outcome worth the use of LIMS? 
5) Were the results of the two parts of the project in agreement?  
 
3.6. Expected results 
Part 1: 
This project was expected to be successful in exposing the benefits of LIMS to 
researchers in academic laboratories. It was expected that the idea of a central repository 
for everything to do with the smooth execution of the project would attract scientist to 
begin to seek to use LIMS in their daily laboratory management. 
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Part 2: 
A large number of scientists were expected to participate in the questionnaire 
survey. It was expected that the results from this study might shed light on factors that 
contribute to the ‘LIMS-lag’ in academia and help software developers meet the 
challenges of making their products available to academics, which would eventually help 
academics in making good and informed decisions about conducting research.  
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CHAPTER FOUR: RESULTS 
 
4.1. General results for LIMS and P450-2D6 genotyping project 
In this project a commercially designed LIMS Biotracker was successfully 
deployed in a genotyping project in a discovery laboratory to achieve the proposed 
objectives of effectively managing workflow. The project was designed to detect a panel 
of nucleotide variants found within the highly genetically polymorphic cytochrome P450-
2D6 gene, the enzyme product of which is involved in the oxidative metabolism of more 
than 100 clinically relevant drugs.  Biotracker LIMS was used to chart the course of the 
entire project, and also to manage and track samples, reagents, and inventories such as 
chemicals, primers, labware, and stock solutions. The work flow component of the LIMS 
provided a palette containing various user created components to create a work flow 
linking all the steps of the genotyping process. Personnel and laboratory information, as 
well as vendor and collaboration information were also managed, as well as secured 
access into the LIMS by all users. 
 
4.1.1. LIMS administration and project management results 
Seven laboratories were created, namely, Biotracker LIMS Administration 
(BTR_LIMS_ADMIN), Clinical Pharmacology (CLIN-PHARM), Laboratory 
Informatics (LAB-INFO), Microbiology, Molecular Biology, QA Department, and 
Virology (Figure 13).  Information created included the address of the laboratory, and 
associated personnel. Of direct interest to this project was the Clinical Pharmacology 
laboratory, where eight (8) users were created under the category of LIMS administrator, 
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professor/head of department, lab manager, technician, and student. Information added to 
user profiles included names, authority level, email addresses, and expiry date in the 
laboratory.  This ensured a centralized repository for personnel information. Only users 
having the required privilege could access this information in LIMS. Also, any 
information in LIMS could be accessed from a remote location, one of the great benefits 
of LIMS. 
 
  
 
Figure 13: Laboratory management 
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From the Administration menu information about personnel was created (Figure 14). This 
included general information, personal information, associated laboratory, images and 
skills. 
 
 
Figure 14: Personnel management 
 
Authority levels were created for all the personnel in the laboratory. In Figure 15 below, 
the Professor/head designation had access to every aspect of LIMS, except a few 
configuration system procedures limited to the LIMS administrator.  Authority level 
assignment included ability to view, delete, save, approve, reject, add, or remove a 
document. Authority level assignment is crucial in the execution of duties or getting 
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access to any part of the LIMS. This also played a role in LIMS security besides 
passwords. 
 
 
Figure 15: Authority level setup 
 
Most projects are carried out with other institutions. In Biotracker, information about all 
collaborations was centralized. This included the address and names of members for 
Johns Hopkins University, Riley Children's Hospital and the School of Informatics, 
Indiana University (Figure 16), with whom the laboratory had collaborations.  
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Figure 16: Collaboration management 
 
Most often information about manufacturers and vendors is hidden in large catalogues or 
online, and much time is lost in searching for information, as well as the products they 
supply. In Biotracker, all information about vendors associated with the laboratory or the 
genotyping project was created and stored in LIMS (Figure 17). This provided a quick 
and easy access to information at any time. A very useful aspect of the vendor 
information is that all supplies obtained from the vendor including catalogue number and 
names of contact persons and their contact information were also included. Vendor 
names appear in the navigation bar and detailed information can be displayed in the work 
area. Vendors associated with the genotype study were linked to the assay catalogue, 
where the kit manufacturer had suggested which vendors had the appropriate equipments 
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and consumables. Detailed information about the particular vendor was then obtained 
online and then inserted into LIMS. Even though this took some time, it took a one time 
effort to assemble all the information into a central repository. Manufacturers and 
vendors included Millipore, Qiagen, Beckman, Corning, and Roche Diagnostics. 
 
 
Figure 17: Vendor information management 
 
Locating samples and inventories in any laboratory can be a challenging task. However, 
Biotracker reduces this time in a very efficient way. Different types of locations were 
created for the Clinical Pharmacology laboratory (Figure 18). This was based on 
conditions in the laboratory, and included freezers, refrigerators, cabinets, rooms, and 
workbenches. Shelves, racks, and boxes were also created. This provided for the minutest 
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detail of the location of reagents, stock solution, samples, instruments, and labware. 
Locations were created for chemicals, stock solutions, labware, instruments, primers, and 
antibodies.  Access to locations was also restricted to personnel in a particular laboratory. 
In the locations window, all other users had security locks on such locations, and could 
not have access in the folder. The locations window also shows the contents of the 
location. Items could be searched for in LIMS by name or barcode, and this will lead 
directly to their location.  
 
 
Figure 18: Location management 
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Figure 19 shows the details of a box created for DNA samples in the laboratory on a rack 
in a freezer in the Clinical Pharmacology Laboratory room 1.  
 
 
Figure 19: Details of box contents 
 
Details of all chemicals for the project as well as others in the laboratory were all created 
through the Inventory menu item. The Inventory menu consists of chemicals, primers, 
antibodies, stock solution, and labware. For instance, clicking on Glycerol in the 
navigation pane brings up all details in the work station window. Information created 
included number of containers, physical and chemical properties, storage conditions, 
vendor, structure (if a compound), material safety data sheets (MSDS), and usage (Figure 
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20). MSDS information is not readily available in a conventional laboratory and one has 
to search for such information. However, this can be readily accessed in LIMS. 
 
 
Figure 20: Chemicals management 
 
Information on stock solution preparation was input through the Inventory and Stock 
Solution menu. Figure 21 shows the preparation of a stock solution of Streptavidin, R-
Phycoerythrin (SA-PE) conjugate.  This allows anyone in the future who wants to prepare 
the SA-PE stock solution to have instant access to its constituents and conditions for 
preparation and storage. Other information created includes number of containers, 
physical and chemical properties, storage conditions, vendor, MSDS, and usage. 
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Enabling stock validation ensured that whenever the amount of chemical or other 
reagents went below a pre-defined level (minimum stock, reorder stock), the item is 
coded red in the stock overview window.  
 
 
Figure 21: Stock solution management 
 
Information for all primers, including orientation, sequence, complements, 
complementary sequence, Genebank ID, containers, physical and chemical properties, 
storage conditions, vendor, MSDS, expiry date, and usage were entered through the 
Inventory-Primers menu (Figure 22). The validate stock option was enabled to ensure 
that whenever the amount of primer went below a pre-defined level (minimum stock, 
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reorder stock) the item is coded red in the stock overview window, and ready for re-
stocking.  
 
 
Figure 22: Primers information management 
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Information for all labware for the project as well as others in the laboratory was stored in 
Biotracker (Figure 23).  
 
 
Figure 23: Labware management 
 
This included information about vendors, location, quantity, received date and barcode. 
The validate stock option was again enabled to ensure that whenever the amount of 
labware went below a pre-defined level (minimum stock, reorder stock), the item is 
coded red in the stock overview window. Labware used included 0.2 mL thin wall 
polypropylene tubes for PCR, 0.5 mL polypropylene microcentrifuge tubes, 1.5 mL 
polypropylene microcentrifuge tubes,  25 mL pipettes, 50 mL polypropylene conical 
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tubes, thin-wall polycarbonate 96-well plates, Seal and Sample Aluminum Foil Lids, 
borosilicate glass tubes (5 or 10 mL),  Microseal, and parafilm. 
Several sample types were created to identify the various products at the end of 
each experimental run (Figure 24). Some of these samples were stored overnight and the 
reactions continued the next day. Therefore, it was necessary to place them in a location 
for easy access at a later date. Sample types created were whole blood, DNA, end-
products from the multiplex PCR, amplicon treatment, multiplex ASPE and bead 
hybridization steps. These products could be stored at 2 to 8 
o
C until ready to use, for a 
maximum of 48 hours. Information on storage conditions was input as well. 
 
 
Figure 24: Experiment sample type management 
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Information for instruments for the project as well as others in the laboratory was stored 
in LIMS. This included information about manufacturer, purchase date, warranty dates, 
person-in-charge, vendors, location, quantity, received date and barcode. Also, 
information about maintenance, validation, contracts, usage and location were stored 
(Figure 25). 
 
 
Figure 25: Instrument management 
 
Several protocols were prepared based on the protocols supplied with the Tag-It mutation 
detection kit for P450 2D6. This was a 12-page manual with 6 different experimental 
steps.  The experimental steps were revised and protocols were generated. This enabled 
protocols to be used at various steps of the workflow. Since these were stored in LIMS, 
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they could be viewed on the computer or printed many times for use. Another advantage 
is the fact that modifications could be made easily at anytime by anyone who is given 
access to the protocol. Privileges are given for accessing protocols, ensuring proprietary 
rights at any time. Incomplete protocols are stored as 'under process protocols', laboratory 
specific protocols are stored as 'Lab protocols', and only personnel from that laboratory 
can view or use them.   Information on any protocol includes name, valid dates, source, 
and steps for execution. Figure 26 shows an approved laboratory-specific protocol for the 
Tag-It sample preparation step. 
 
 
Figure 26: Protocol management 
 
Among the protocols generated were  
(1) Tag-It DNA Extraction for DNA extraction based on directions from Qiagen 
(2) Tag-It Sample Preparation Multiplex PCR for preparing the PCR primer products 
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(3) Tag-It Amplicon treatment for the amplicon treatment of the PCR primer products 
(4) Tag-It Multiplex ASPE for mixing the PCR amplicons with the ASPE primer mix 
(5) Tag-It Bead Hybridization for the hybridization of the products from the ASPE step 
with the bead mix 
(6) Tag-It data acquisition with the Luminex 100 xMAP system 
(7) Tag-It data analysis with the Tag-It data Analysis software  
 Whenever changes are made to an existing protocol, a new version is created. The 
version number of the new protocol is system generated.  Protocols were used to set up 
the experiment templates for the LIMS_TagIt P450 2D6_SP project, and the experiment 
templates were used to set up the project.   Project Management module in Biotracker 
allows a researcher to establish a hierarchical model for project creation. Through the 
General window under Project Management (Library menu) details of the project were 
created (Figure 27). This included person-in-charge, and planned start and end dates.   
 
Figure 27: Project setup 
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Time schedules were set up for the execution of each of the steps of the protocol.  This 
was created as a map (Figure 28) and was linked with a diagrammatic workflow of the 
project (Figure 29). A hierarchical system of workflow leads to easy resource appraisals 
and result validations. The researcher gets a composite picture of required resources and 
expected outputs involved. Once a project has been created, samples, personnel, 
instruments, and experiments (Figure 30) can be linked to it using the workflow. This can 
aid the decision-making process.  
 
 
Figure 28: Project schedule management 
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Figure 29: Project workflow 
 
Figure 30: Project experiments 
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Figure 31 shows the 96-well plate composition from the Tag-It Bead hybridization step 
just before data acquisition. 
 
 
Figure 31: Plate management 
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Figure 32 shows the details of the plate contents. This enables a researcher to trace back 
to the origin of the individual samples. 
 
 
Figure 32: Plate content details 
 
 
The final results generated with the Tag-It Data analysis software showed the variations 
for each sample (Figures 33 and 34 for two samples). A determination of whether the 
wild-type/mutant allele for each of the 12 small nucleotide variants had been detected or 
whether the samples carry an allele with the deletion or duplication was then made 
(Figure 35).  The Tag-It Data Analysis Software displays, for each sample, the calls for 
the variations. The possible calls for a given variation of a specific sample are: 
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Bi-allelic variations (presence of two different gene forms or alleles): 
WT: only the wild-type allele has been 
HET: both the wild-type and the mutant alleles have been detected 
MUT: only the mutant allele has been detected 
No Call: a call could not be made  
 
Gene copy variation (duplication and deletion) 
ND: specific gene copy variation not detected (duplication or deletion) 
DUP/DEL: duplication or deletion detected 
No Call: a call could not be made   
 
 
Figure 33: Complete variant call data for an individual sample 
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Figure 34: Complete variant call data for another individual sample 
 
 
Figure 35: Complete call for all samples 
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This data was exported into LIMS and managed through the Document management 
module. Privileges can be assigned to who should see the data. Data checked in or out 
can also be monitored with LIMS (Figure 36). 
 
 
Figure 36: Document management 
 
4.1.2. LIMS administration and project management reports 
Different reports can be generated with the Report module on the main menu. 
Reports of interest generated included:  
(1) Stock overview report which shows all the inventories one selected and their 
quantities (Figure 37). 
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(2) Inventory threshold report shows how much of each item is left, and therefore should 
be re-ordered. Items running below threshold stock are shown in red (Figure 38).  
(3) Overall project report: This shows the final report of a project and shows the 
experiments, runs, inventory, personnel, time schedule, who submitted the project, who 
approved runs, experiments and project, instrument schedules, and names of all files and 
documents associated with the project (Appendix A). 
 
 
Figure 37: Stock overview report 
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Figure 38: Inventory threshold report 
 
4.2. LIMS in academic research 
Respondents to questionnaires and phone interviews were given a definition of LIMS as 
computer software that is used in the laboratory for the management of samples, 
laboratory users, instruments, standards, and other laboratory functions such as invoicing, 
plate management, and workflow automation. They were then asked to fill out the 
questionnaires or respond via phone. 
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A total of 100 questionnaires and phone interviews were conducted. The response 
was 32/100 (32%).  Out of this, 23 were male scientist (71.9%) and 9 females (28.1%) 
(Table 1). 
 
Table 1: Sex 
Most of the respondents were between the ages of 31 and 50 (71.9%) (Table 2), and 
majority (71.9%) had 5 or more years of experience in their field of study (Table 3).   
 
Table 2: Age 
 
Table 3: Experience in field 
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Field of expertise varied greatly, but there was a broad representation of scientists in 
research (Figure 39). The rationale behind the question was to find out which field of 
research would most likely use LIMS. 
 
Figure 39: Field of research expertise 
 
Table 4 shows most respondents come from laboratories where there were more than 6 
scientists (53.1%). This question was posed to find out whether the number of people in a 
laboratory may influence the decision to use LIMS. 
 
Table 4: Number of staff present in laboratory 
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Table 5 shows that majority of respondents said their laboratories had modern and 
adequate equipment (68.8%). The question was to help determine whether the use of 
modern technology had a relation with LIMS use. 
 
Table 5: Laboratory technology 
 
 
Both private and public institutions were almost equally represented (Table 6). This 
question was to ascertain which type of institution, public or private, will have more 
people using LIMS. 
 
 
Table 6: Institution 
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Majority of respondents worked more than 5 hours a day during the week (90.7%) (Table 
7), and majority did not work on weekends (68.8%) (Table 8). The question was to 
ascertain whether time in research facility influenced LIMS use.  
 
Table 7: Working hours - week days 
 
 
Table 8: Working hours - weekend 
The use of software technology was analyzed with six items namely, using software to 
automatically record any part of an experiment (SFrecTime), to transfer experimental 
results automatically from measuring equipment or instrument to storage site 
(SFtrnresSto), to record every change made to records (SFrecChng), to detect who 
performed an experiment (SFdetectUser), to detect when experiment was performed 
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(SFexpTime), or to automatically run an experiment (SFautoRunExp).  Responses were 
grouped under Never-1, Rarely-2, Sometimes-3, Often-4, or Always-5.  As shown in 
Figure 40, the distribution of responses to using software to automatically record any part 
of an experiment or to transfer experimental results automatically from measuring 
equipment or instrument to storage site were fairly normal. However, responses to using 
software to record every change made to records, to detect who performed an experiment, 
or to detect when experiment was performed, or to automatically run an experiment, all 
were skewed to the left of the distribution. Reliability testing resulted in a Cronbach’s 
alpha of 0.796. Hence, the reliability for using all six items as an index was high 
(reliability coefficient of 0.70 or higher is considered "acceptable" in most Social Science 
research situations). Software technology was then used in further analysis as an index 
for analyzing LIMS use.  
 
Figure 40: Software technology used 
Never-1, rarely-2, sometimes-3, often-4, always-5 
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Responses to how long LIMS had been used are given in Table 9.  Length of LIMS use 
was to help identify respondents who had or had not used LIMS.  Hence, respondents 
were classified into two groups of whether they had used LIMS before, Yes-25%, Never - 
75%. These two groups were then used for analysis in subsequent testing. 
 
Table 9: Time of LIMS use 
Multiple regression analysis of the correlation between LIMS usage (Yes or Never) and 
the demographic measures are shown in Table 10. None of the demographic correlated 
statistically significant with LIMS usage. For Sex, the negative correlation (-.040, 
p=.414) indicates that more Males (assigned 1) than Females (assigned 2) were more 
likely to use LIMS.  
 
Table 10: Factors affecting LIMS use 
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The negative correlation between Age and LIMS use (R=-.040, p=0.414) indicates that 
more young scientist (lower scale of 2 and 3) than older ones (scale of 4) correlated with 
LIMS use. For Institution, the negative correlation (R=-.181, p=0.161) indicates that 
scientists in private (scale 1) than public institutions (scale 2) correlated with LIMS use. 
The less time (scale 1-2) a scientist spends working at the weekend correlated with LIMS 
use (R=-0.190, p=0.149) than more time spent (scale 3-5). Scientists with more adequate 
and modern equipment in their own laboratory (lower scale of 1) correlated with LIMS 
use (R=-0.145, p=0.214). These correlations were however, not statistically significant. 
  
Linear regression analysis was used to determine the overall fit of the software 
technology model. Table 11 shows the percentage accounting for the variation in LIMS 
use by each of the software technology use responses.  Overall this model accounts for 
7.9%, hence, 92.1% of the variation in LIMS use cannot be accounted for by software 
technology responses alone.  
 
 
Table 11: Software technology and LIMS use 
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Table 12 shows LIMS is implemented mostly in gene expression and genotyping studies 
(40%).  
 
Table 12: LIMS functionality used 
 
Reasons given for why LIMS has never been used showed that lack of knowledge about 
LIMS (43.8%) was the main factor, followed by unavailability (21.9%) (Table 13). 
 
Table 13: Reasons for not having used LIMS 
 63 
 
CHAPTER FIVE: DISCUSSION 
 
5.1. Implementation of LIMS in a genotyping study 
 
5.1.1. Explanation of outcome 
In this project a commercial LIMS was successfully implemented in a genotype 
study to track workflow from protocol designing, sample acquisition, genotyping, data 
acquisition and analysis, to record generation. Besides serving as a workflow manager, 
the Biotracker LIMS also provided visible quality checks and centralization of data 
(Figure 40). The ability to track data and communicate quality information helps a 
laboratory to improve methods and work practices.  
A challenging task facing life science researchers in small-sized laboratories is to 
effectively manage the entire process as well as the data that is generated.  In a 
genotyping laboratory, this task can be most challenging, given the nature of the 
workflow.  Samples may possibly fail at different steps of the workflow, resulting in a 
need to repeat the process from the start. Records for a particular sample may need to be 
revised over time, and data storage becomes a key issue.  Segregation of steps, ineffective 
inventorying practices, and no easy way of collating all the data to draw meaningful 
inferences are among some of the challenges faced. Usually, data is managed using a 
combination of Microsoft Excel, Word, and sometimes publicly available tools and in-
house applications.  
 Biotracker is an application designed for use in different discovery studies. Its 
modular design can be used to meet a laboratory's specific needs by combining modules. 
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In this study, its genotyping functionality was used. After the genotype workflow had 
been established, the use of the overall system led to a minimization of manual user input 
and paperwork. Biotracker presents a friendly and intuitive user interface, and users 
navigate within the application through several navigation options, using menus that 
follow the laboratory workflows. The interface includes several display screens that are 
specific for each step in the process and in which the related data are presented in tables 
and windows. Some of the functions are managed through forms that use pull-down 
menus users create, and this helped to minimize form-filling errors. Validations checks 
were made possible during system configuration of the data type, units, dates, as well as 
integrity with respect to other tables in the database.  Users are guided through the 
workflows by being prompted to fill the required fields of one step before moving on to 
the next step. Sometimes, an experimental step needs to be approved by an authority 
before one can move to another step, placing more checks on the integrity of the overall 
data. Barcodes were used to track samples and inventories, and most activities are 
monitored or executed with the user’s name and password. Data could also be imported 
in bulk, reducing errors due to manual entry. LIMS can also import and store data from 
different forms of applications, and therefore provides a central repository for all the 
information and data for the genotyping process (Figure 41).  
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Figure 41: Integration of information with LIMS 
 
Although LIMS are effective in the pharmaceutical and biotech industries, most 
are too costly and not readily available for small research labs. As mentioned earlier, 
individual laboratories have designed their own LIMS to fit their particular research, but 
this took time and effort, and may not be easily adopted by other laboratories. However, 
with academic pricing now becoming available from the commercial software designers, 
the money spent may become worth the efficiency in research execution and overall 
outcome of data from academic laboratories.    
 
5.1.2. Importance of outcome 
The use of LIMS in combination with automation of laboratory processes 
improves the efficiency and quality of the work by reducing potential for human errors, 
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accelerating the throughput of analysis, and enables sample tracking activities that are 
very difficult to perform without error by hand. This study shows that academic 
laboratories can use commercial LIMS to effectively manage workflow, store data, and 
get data off instruments into storage systems, and doing so in a manner that is lossless 
and not sacrificing speed for interruptions in data. Another feature of LIMS observed in 
this study is securing data and proprietary information with the use of access-restricted 
items such as passwords and electronic signatures.  
 
5.2. Implementation of LIMS in academic research 
 
5.2.1. Outcome of study 
This study found that there were low correlations between demographic factors 
such as age, sex, experience, field of expertise, type of academic institution, number of 
scientific personnel in laboratory, and the type of technology used, and LIMS usage. 
None of these correlations were significant. No combination of these factors could 
constitute an index with a reliability coefficient high enough to be acceptable. It was also 
observed that there is a disparate use of software technologies in academia.  Researchers 
use different software technologies in segregated steps, such as to record any part of an 
experiment, to automatically transfer results to final storage site, or to automatically run 
an experiment. Very few respondents reported using a single software to carry out most 
of their processes. Owing to this, software technology could not be used as a model to 
predict actual LIMS use, despite an "acceptable" reliability coefficient obtained for the 
six items used together as an index to test LIMS usage (0.796). The correlation 
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coefficient between this index and LIMS usage computed from having or never having 
used LIMS before, were very low and not statistically significant. LIMS was not found to 
be widespread in academia (75% never-users), but where they were present they are 
mostly used for studies involving genotyping and gene sequencing. The major reason for 
lack of LIMS use is lack of knowledge about them. Perry (2002) found a similar trend 
together, with financial constraints, but in this study financial constraint was one of the 
reasons least cited.    
 
5.2.2. Implication of study 
The outcome of this study implies that LIMS software companies should 
advertise their products by encouraging academic researchers to try them out first. When 
the benefits of such system become evident, scientists are more likely to use them. Also 
some of the modules and functionalities of commercial LIMS could be deleted to fit 
academic research needs and budget.  Despite having the latest and sophisticated 
equipments in their laboratories, much attempt is not made to research the need for 
software systems such as LIMS to aid research. As many as 68.8% of respondents 
reported having modern and adequate equipments in their laboratory as opposed to just 
25% having used LIMS before.  Academic research may seem to be fragmented and 
therefore one LIMS may be difficult to meet all functions. However, LIMS like 
Biotracker feature different modules that can be adapted for different functionalities. 
Therefore, both LIMS vendors and academic scientists need to work together to bridge 
this knowledge divide. 
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CHAPTER SIX: CONCLUSION 
 
6.1. Limitations of study 
Both studies presented with some challenges and these are outlined below. 
 
6.1.1.  LIMS implementation in genotype studies 
The full functionality of Biotracker was not used in this study as this was a 
limited version. However, the functionalities used were enough to see the benefits of 
LIMS implementation in a genotyping workflow. Of particular benefit was the location 
management functionality which eased the search for inventories for the project. This 
was a fairly busy laboratory with many tissue, sample, and reagent storage facilities. At 
the end of the study, the scientists were impressed with the usefulness of LIMS. A key 
feature of LIMS is instrument integration. This functionality was not available on the 
student version of the LIMS, but this did not present much difficulty in transferring data 
into LIMS from the bioanalyzer used. 
 
6.1.2.  LIMS implementation in academic research  
A greater sample size may present a much more diverse result for analyses.  A 
better outcome might have been seen if the questionnaire had been web-based. 
Questionnaire research by email is becoming increasingly difficult as mails are screened 
for solicitation or lack thereof, and most often attachments are rejected. However, in 
some instances, initial emails to ask for permission came back with responses of scientist 
being busy or unavailable.  This was a two-page 16-item questionnaire, with the rationale 
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to cut down on time for filling them out. However, more indices examining LIMS use 
may shed more light on factors that contribute to the ‘LIMS-lag’ in academia,  and help 
software developers meet the challenges of making their products available to academics. 
This may also eventually help academics in making good and informed decisions about 
conducting research, and help to implement some of these sophisticated and useful tools 
for their research. 
 
6.2. Further research 
It is hoped that future research will involve a whole academic laboratory adopting 
Biotracker LIMS for a similar study to determine the usefulness of LIMS. At the same 
time, an investigator could perform an ethnographic study to evaluate in details the 
practices associated with LIMS usage in academia to shed more light on the lack of use. 
It is possible that unwillingness to change the status quo could be playing a major role. 
 
6.3. Summary 
A commercial LIMS was successfully implemented in a genotyping study in an 
academic laboratory to integrate all steps and data management activities for efficient 
workflow. LIMs use in academic research is very fragmented and limited, and lack of 
knowledge of its existence and usefulness was cited as the major reason for this situation. 
Both software vendors and academic researchers need to work together to close the 
divide between them, as this has a negative impact on both business and academic 
research. Academic scientists are missing out on a potentially valuable research 
technology in LIMS, and LIMS developers and vendors are missing the opportunity to 
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establish themselves in the larger scientific community. With the completion of the 
human genome project and the race to find answers to life's medical issues, LIMS may 
play a big role in discovery laboratories such as those in academia. 
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Appendix B: Questionnaire 
Dear Scientist,  
This questionnaire has been designed to solicit your responses to issues about knowledge, 
attitude, and implementation of Laboratory Informatics Management System (LIMS) in 
your current laboratory.  A LIMS is computer software that is used in the laboratory for 
the management of samples, laboratory users, instruments, standards and other laboratory 
functions such as invoicing, plate management, and work flow automation. Your response is 
very much appreciated.  
 
Part A: (Select and insert your response in the last column) 
 ITEM CHOICES Response 
A1 Sex Male (1)        Female (2)  
A2 Age 20-30 yrs  (1)   30-40 yrs  (2)   40-50 
yrs  (3)  
50 yrs +(4) 
 
A3 City    
A4 State (Two-letter abbreviation  only)   
A5 Type of academic 
institution 
Private (1)      Public (2)  
A6 Field of expertise        
A7 How long have you 
worked in this field? 
< 1 yr (1)  1-2 yrs (2) 3-5 yrs (3)              
5+ yrs (4) 
 
A8 How long have you 
worked in present 
laboratory? 
< 1 yr  (1) 1-2 yrs (2) 3-5 yrs (3)   
5+ yrs (4) 
 
A9 How many hours a day do 
you spend working in the 
laboratory? 
< 1 hr (1)  1-4 hrs (2) 5-8 yrs (3)              
8+ hrs (4) 
 
 
A10 How many hours do you 
spend working in the 
laboratory at the 
weekends? 
Never (1)     < 1 hr (2)  1-4 hrs (3)         
5-8 yrs (4)  8+ hrs (5) 
 
A11 How many scientific or 
technical people (e.g., 
professors, postdoctorates, 
students, and technicians) 
are present in your 
laboratory? 
 
 
Only one (1)   < 3 (2)      3-5 (3)     
6+ (4) 
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A12 How would you rate your 
laboratory in terms of 
modern technology? 
Equipments present in own laboratory, 
modern, adequate (1) 
Equipments present in own laboratory, 
outdated, adequate (2)                         
Equipments present in own laboratory, 
modern, inadequate (3) 
Equipments present in own laboratory, 
outdated, inadequate (4) 
Rely entirely on core facilities 
equipments (5) 
 
 
Part B: (Select and insert your response in last column) 
  
ITEM 
 
CHOICES 
 
Response 
B1 How often have you used any 
of these technologies below? 
 
 
 
 
 
 
 
Never (1)  Rarely (2) Sometimes (3)  
Often (4)    Always (5) 
 
Software to electronically and 
automatically record any part of 
your experiment   
 
Software to transfer your 
experimental results automatically 
from your measuring equipment or 
instrument to storage site   
 
Software program to electronically 
record every change you make to 
your records 
 
Software program to detect who 
performed an experiment  
 
Software program to detect when a 
real experiment was performed 
 
Software program to automatically 
run an experiment 
 
B2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
If you use LIMS select from 
among the list those items that 
best describe the 
functionalities you use (Insert 
X in the Response column)   
 
 
 
 
 
 
Sequencing  
Gene expression  
Genotyping assays  
Proteomics core labs  
Bio-specimen banking facilities  
Laboratory administration   
Study design and scheduling  
Workflow design and execution  
Inventory management and tracking system  
Audit trails  
Report building  
Protocol building  
Instrument integration for automated data 
capture 
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Review and approval of documents  
Other  
B3 How long have you used 
LIMS? 
 
Never (1)    < 1mo  (2)  1-6 mos   (3)        
7– 23mos (4)     2-5yrs  (5)  5+ yrs  
(6)  
B4 What reasons account for your 
not having used LIMS before? 
(Insert X in the Response 
column)   
 
Unavailability  
Financial constraints  
Do not know much about it  
Will not affect research productivity  
Other…………………….    
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